Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iopidine for Ocular Synkinesis
NCT05167760Phase 4Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Dec 2025
- Primary completion
- Nov 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of apraclonidine in Synkinesis, sponsored by University of Alabama at Birmingham. Planned start Dec 2025; status: withdrawn.
02
Drugs
apraclonidine
03
Conditions
Synkinesis
Beyond the preview
Go deeper on NCT05167760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05167760.